Drug Profile
Herpes simplex vaccine - Xenova
Alternative Names: DISC HSV; DISC HSV-1; DISC HSV-2; GW 419458; TA HSVLatest Information Update: 17 Jan 2005
Price :
$50
*
At a glance
- Originator Xenova Group
- Class Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Herpes simplex virus infections
Most Recent Events
- 17 Jan 2005 The DISC-HSV Vector platform has been licensed to Oxxon Therapeutics worldwide
- 15 Oct 2001 The agreement with GSK to co-develop TA HSV will be terminated effective January 2002
- 15 Oct 2001 Discontinued-II for Herpes simplex virus infections in United Kingdom (SC)